Nonclinical Cardiovascular Studies of Prucalopride, a Highly Selective 5-Hydroxytryptamine 4 Receptor Agonist

Journal of Pharmacology and Experimental Therapeutics - United States
doi 10.1124/jpet.117.244079
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

Role of Prucalopride, a Serotonin (5-Ht4) Receptor Agonist, for the Treatment of Chronic Constipation

Clinical and Experimental Gastroenterology
Gastroenterology
2010English

Effects of 5-Hydroxytryptamine 2C Receptor Agonist MK212 and 2A Receptor Antagonist MDL100907 on Maternal Behavior in Postpartum Female Rats

Pharmacology Biochemistry and Behavior
PharmacologyBiochemistryClinical BiochemistryBehavioral NeuroscienceToxicologyBiological Psychiatry
2014English

Cardiovascular Effects of Intravenous Infusions of 5-Hydroxytryptamine in Man

British Journal of Pharmacology and Chemotherapy
1959English

5-Ht3 Receptor Antagonism by Anpirtoline, a Mixed 5-Ht1 Receptor Agonist/5-Ht3 Receptor Antagonist

British Journal of Pharmacology
Pharmacology
1995English

5-Hydroxytryptamine

Postgraduate Medical Journal
Medicine
1958English

Anandamide, an Endogenous Cannabinoid Receptor Ligand, Also Interacts With 5-Hydroxytryptamine (5-Ht) Receptor.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
1998English

A Novel Tissue-Selective Β2-Adrenoceptor Agonist With Minimized Cardiovascular Effects, 5-Hob, Attenuates Neuropathic Pain in Mice

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2019English

Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome

English

Characterization of Binding, Functional Activity and Contractile Responses of the Selective 5‐HT 1F Receptor Agonist Lasmiditan

British Journal of Pharmacology
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy